Treatment for Mild Chronic Hypertension During Pregnancy Article

Full Text via DOI: 10.1097/01.ogx.0000852888.79526.c3 Web of Science: 000832442600006

Cited authors

  • Tita AT, Szychowski JM, Boggess K, Dugoff L, Sibai B, Lawrence K, Hughes BL, Bell J, Aagaard K, Edwards RK, Gibson K, Haas DM, Plante L, Metz T, Casey B, Esplin S, Longo S, Hoffman M, Saade GR, Hoppe KK, Foroutan J, Tuuli M, Owens MY, Simhan HN, Frey H, Rosen T, Palatnik A, Baker S, August P, Reddy UM, Kinzler W, Su E, Krishna I, Nguyen N, Norton ME, Skupski D, El-Sayed YY, Ogunyemi D, Galis ZS, Harper L, Ambalavanan N, Geller NL, Oparil S, Cutter GR, Andrews WW


  • (Abstracted from N Engl J Med 2022;386:1781-1792) Chronic hypertension develops in 2% of pregnancies in the United States. As this condition disproportionately affects Black women and is associated with 3 to 5 times the risk of placental abruption, preeclampsia, preterm birth (PTB), small-for-gestational-age (SGA) birthweight, and perinatal death, optimizing treatment is critical to possibly preventing these associated complications.

Publication date

  • 2022

International Standard Serial Number (ISSN)

  • 0029-7828

Number of pages

  • 3

Start page

  • 460

End page

  • 462


  • 77


  • 8